Loading company…
Unicar-Therapy develops CAR-T and other cell and gene therapy products.
Founded in 2015 and based in Shanghai, China, Unicar-Therapy develops CAR-T and other cell and gene therapies for tumor treatment. It has built antibody screening platforms and GMP production bases, and collaborated with hospitals on more than 1,000 CAR-T clinical studies and treatments. In September 2020, SSCART-19 injection received approval for a formal clinical trial.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in